SEC Company Response from Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI) — Dec 15, 2020
Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: Dec. 15, 2020 · CIK: 0001799788 · Accession: 0001493152-20-023672
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
Greenwich
LifeSciences, Inc.
3992
Bluebonnet Dr, Building 14
Stafford,
TX 77477
December
15, 2020
VIA
EDGAR
United
States Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Jeffrey Gabor
Re:
Greenwich
LifeSciences, Inc. (CIK: 0001799788)
Registration
Statement on Form S-1
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Greenwich
LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred
to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, December 17, 2020,
or as soon thereafter as possible.
Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
GREENWICH
LIFESCIENCES, INC.
By:
/s/
Snehal Patel
Name:
Snehal
Patel
Title:
Chief
Executive Officer